What is the address of PRIMUM NON NOCERE - DR. CARL STEYLAERTS?

The registered office of PRIMUM NON NOCERE - DR. CARL STEYLAERTS is located at Citadellaan 2bis, 3293 Diest.

Is PRIMUM NON NOCERE - DR. CARL STEYLAERTS still active?

Yes. According to the CBE (27 September 2026) PRIMUM NON NOCERE - DR. CARL STEYLAERTS is active, legal situation “Normale toestand”, started on 5 April 2000.

Is PRIMUM NON NOCERE - DR. CARL STEYLAERTS registered on Peppol?

Yes, PRIMUM NON NOCERE - DR. CARL STEYLAERTS is registered on the Peppol network with ID 0208:0471608951.

What is the enterprise number of PRIMUM NON NOCERE - DR. CARL STEYLAERTS?

The enterprise number of PRIMUM NON NOCERE - DR. CARL STEYLAERTS is BE0471608951.

When was PRIMUM NON NOCERE - DR. CARL STEYLAERTS founded?

PRIMUM NON NOCERE - DR. CARL STEYLAERTS was founded on 5 April 2000.

Who are the directors of PRIMUM NON NOCERE - DR. CARL STEYLAERTS?

According to the 2025 annual accounts, the directors of PRIMUM NON NOCERE - DR. CARL STEYLAERTS are: CARL STEYLAERTS.

Is PRIMUM NON NOCERE - DR. CARL STEYLAERTS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 April 2000; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PRIMUM NON NOCERE - DR. CARL STEYLAERTS make in 2025?

PRIMUM NON NOCERE - DR. CARL STEYLAERTS posted a profit after taxes of € 14,353 in financial year 2025.

What is the revenue of PRIMUM NON NOCERE - DR. CARL STEYLAERTS?

As a small company, PRIMUM NON NOCERE - DR. CARL STEYLAERTS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 40,898.

PRIMUM NON NOCERE - DR. CARL STEYLAERTS (Private Limited)

Dossier PRIMUM NON NOCERE - DR. CARL STEYLAERTS, printed on 27 September 2026 from databakkes.be/en/0471608951/primum-non-nocere-dr-carl-steylaerts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PRIMUM NON NOCERE - DR. CARL STEYLAERTS from Diest, company number BE0471608951, closed financial year 2025 with a result of € 14,353 after tax. For that financial year PRIMUM NON NOCERE - DR. CARL STEYLAERTS recorded a gross margin of € 40,898 and equity of € 114,933. Compared with financial year 2024, the result moved from € 15,315 to € 14,353. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Growing

€ 114,933

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 14,353

▼ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 60,256

▲ 117% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 102,433.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 59,019

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 191

▲ 26% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 19,468

▲ 3% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 33,978 Gross margin 2022: € 33,978 First fiscal year in the series	€ 32,881 Gross margin 2023: € 32,881 ▼ 3% vs 2022 (€ 33,978) Unfavourable step	€ 38,623 Gross margin 2024: € 38,623 ▲ 17% vs 2023 (€ 32,881) Favourable step	€ 40,898 Gross margin 2025: € 40,898 ▲ 6% vs 2024 (€ 38,623) Favourable step	▲ 6%
Profit after taxes	€ 22,733 Profit after taxes 2022: € 22,733 First fiscal year in the series	€ 21,305 Profit after taxes 2023: € 21,305 ▼ 6% vs 2022 (€ 22,733) Unfavourable step	€ 15,315 Profit after taxes 2024: € 15,315 ▼ 28% vs 2023 (€ 21,305) Unfavourable step	€ 14,353 Profit after taxes 2025: € 14,353 ▼ 6% vs 2024 (€ 15,315) Unfavourable step	▼ 6%
Equity	€ 73,959 Equity 2022: € 73,959 First fiscal year in the series	€ 85,265 Equity 2023: € 85,265 ▲ 15% vs 2022 (€ 73,959) Favourable step	€ 100,580 Equity 2024: € 100,580 ▲ 18% vs 2023 (€ 85,265) Favourable step	€ 114,933 Equity 2025: € 114,933 ▲ 14% vs 2024 (€ 100,580) Favourable step	▲ 14%
Total debts	€ 36,553 Total debts 2022: € 36,553 First fiscal year in the series	€ 36,601 Total debts 2023: € 36,601 Unchanged (€ 36,553) Unfavourable step	€ 19,257 Total debts 2024: € 19,257 ▼ 47% vs 2023 (€ 36,601) Favourable step	€ 19,660 Total debts 2025: € 19,660 ▲ 2% vs 2024 (€ 19,257) Unfavourable step	▲ 2%
Cash	€ 96,664 Cash 2022: € 96,664 First fiscal year in the series	€ 103,621 Cash 2023: € 103,621 ▲ 7% vs 2022 (€ 96,664) Favourable step	€ 27,800 Cash 2024: € 27,800 ▼ 73% vs 2023 (€ 103,621) Unfavourable step	€ 60,256 Cash 2025: € 60,256 ▲ 117% vs 2024 (€ 27,800) Favourable step	▲ 117%
Retained profit	€ 61,459 Retained profit 2022: € 61,459 First fiscal year in the series	€ 72,765 Retained profit 2023: € 72,765 ▲ 18% vs 2022 (€ 61,459) Favourable step	€ 88,080 Retained profit 2024: € 88,080 ▲ 21% vs 2023 (€ 72,765) Favourable step	€ 102,433 Retained profit 2025: € 102,433 ▲ 16% vs 2024 (€ 88,080) Favourable step	▲ 16%
Dividend	€ 10,000 Dividend 2022: € 10,000 First fiscal year in the series	€ 10,000 Dividend 2023: € 10,000 Unchanged (€ 10,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 10,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 110,512 Balance sheet total 2022: € 110,512 First fiscal year in the series	€ 121,865 Balance sheet total 2023: € 121,865 ▲ 10% vs 2022 (€ 110,512) Unchanged	€ 119,837 Balance sheet total 2024: € 119,837 ▼ 2% vs 2023 (€ 121,865) Unchanged	€ 134,593 Balance sheet total 2025: € 134,593 ▲ 12% vs 2024 (€ 119,837) Unchanged	▲ 12%

Key figures of PRIMUM NON NOCERE - DR. CARL STEYLAERTS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PRIMUM NON NOCERE - DR. CARL STEYLAERTS?

What happened at PRIMUM NON NOCERE - DR. CARL STEYLAERTS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 27, 2026 New annual accounts for financial year 2025: profit of € 14,353 (▼ 6% vs 2024). Source: NBB ↗
Apr 5, 2000 Start of the company according to the CBE. KBO

In short

From € 22,733 profit in 2022 to € 14,353 profit in 2025.

Paid € 26,037 in corporate taxes since 2022.

Best year ever: 2022, with € 22,733 profit.

Paid out € 20,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at PRIMUM NON NOCERE - DR. CARL STEYLAERTS? We notify you, reason included.

Follow PRIMUM NON NOCERE - DR. CARL STEYLAERTS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

CARL STEYLAERTS

PRIMUM NON NOCERE - DR. CARL STEYLAERTS

Behind PRIMUM NON NOCERE - DR. CARL STEYLAERTS is CARL STEYLAERTS.

See the full network in the app

Directors

According to the 2025 annual accounts

CARL STEYLAERTS

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Citadellaan 2bis

3293 Diest

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0471.608.951
VAT number: BE 0471.608.951
Registered office: Citadellaan 2bis, 3293 Diest
Names & denominations: PRIMUM NON NOCERE - DR. CARL STEYLAERTS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 April 2000
Peppol: Active · Active since 3 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗